Literature DB >> 25055118

The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.

Alexandre Janel1, Frédérique Dubois-Galopin, Céline Bourgne, Juliette Berger, Karin Tarte, Nathalie Boiret-Dupré, Stéphane Boisgard, Pierre Verrelle, Pierre Déchelotte, Olivier Tournilhac, Marc G Berger.   

Abstract

The systematic localization of chronic lymphocytic leukemia (CLL) B-cells in the bone marrow (BM), together with the ex vivo protective effect of stromal cells on their spontaneous apoptosis, both indicate a specific role of the BM microenvironment. In vivo, the impact of CLL cells on mesenchymal stromal cells (MSCs) remains a source of debate. Here, we quantified and expanded colony forming unit-fibroblasts (CFU-Fs) from CLL-BM under standard conditions, analyzed the expression of selected genes, and studied secretion profiles. We observed failing of CLL-BM cultures in standard conditions (45.5% vs. <0.1%), and even after adding basic fibroblast growth factor (bFGF), there were fewer CFU-F than from normal BM (1.3 vs. 40/10(6) cells respectively; P<0.01). Furthermore, their polygonal aspect and low proliferative capacity, together with the expression of 384 selected genes and a secreted set of molecules related to senescence-associated secretory phenotype indicated a state of senescence, further confirmed by the higher proportion of senescence-associated β-galactosidase (SA-βGAL)-positive cells and p16INK4a overexpression. In our hands, hypoxic conditions (5% O2) did not rescue CFU-Fs. Given the role of MSC in BM tissue organization, we studied hematons that are generally considered to be elementary BM units. These structures were rare or had even disappeared completely. When hematons were present, we systematically observed nodular B-CLL cell invasion only. These data confirm that the B-CLL clone has a marked impact on MSC and disrupts BM organization in vivo, raising new questions about in vivo pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25055118     DOI: 10.1089/scd.2014.0229

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  7 in total

Review 1.  Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.

Authors:  Elisa Ten Hacken; Jan A Burger
Journal:  Biochim Biophys Acta       Date:  2015-07-17

Review 2.  Bone Marrow Niches of Hematopoietic Stem and Progenitor Cells.

Authors:  Oleg Kandarakov; Alexander Belyavsky; Ekaterina Semenova
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

3.  Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients.

Authors:  Bryce A Manso; Henan Zhang; Molly G Mikkelson; Kimberly A Gwin; Charla R Secreto; Wei Ding; Sameer A Parikh; Neil E Kay; Kay L Medina
Journal:  Leukemia       Date:  2018-10-05       Impact factor: 11.528

4.  Increased phosphorylation of eIF2α in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes.

Authors:  Paulina Podszywalow-Bartnicka; Anna Cmoch; Magdalena Wolczyk; Lukasz Bugajski; Marta Tkaczyk; Michal Dadlez; Margaret Nieborowska-Skorska; Antonis E Koromilas; Tomasz Skorski; Katarzyna Piwocka
Journal:  Oncotarget       Date:  2016-11-29

5.  Chronic lymphocytic leukemia B-cell-derived TNFα impairs bone marrow myelopoiesis.

Authors:  Bryce A Manso; Jordan E Krull; Kimberly A Gwin; Petra K Lothert; Baustin M Welch; Anne J Novak; Sameer A Parikh; Neil E Kay; Kay L Medina
Journal:  iScience       Date:  2020-12-26

6.  Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication.

Authors:  Pin Lu; Shengchun Wang; Carrie A Franzen; Girish Venkataraman; Rebecca McClure; Lei Li; Wenjun Wu; Nifang Niu; Madina Sukhanova; Jianming Pei; Donald A Baldwin; Reza Nejati; Mariusz A Wasik; Nadia Khan; Yifan Tu; Juehua Gao; Yihua Chen; Shuo Ma; Richard A Larson; Y Lynn Wang
Journal:  Blood Cancer J       Date:  2021-02-18       Impact factor: 9.812

Review 7.  Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells.

Authors:  Oleg Kandarakov; Alexander Belyavsky
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.